The influence of ApoE4 on signaling & poor outcome after traumatic brain injury
The influence of ApoE4 on signaling & poor outcome after traumatic brain injury
批准号:
10266025
负责人:
Naomi Ledene Sayre
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2022-06-30
关键词:
AcuteAdvisory CommitteesAffectAfghanistanAgingAllelesAmyloid beta-ProteinApolipoprotein EAstrocytesAttenuatedBehaviorBindingBiologyBrainBrain InjuriesCell Culture TechniquesCell DeathCell SurvivalCell membraneCellsChronicCoculture TechniquesCritical ThinkingCytokine SignalingCytosolDataDisease ProgressionEdemaEndocytosisEndosomesEnvironmentEvaluationFosteringFundingFutureGJB6 geneGenetic RecombinationGoalsHeadacheHealthImpairmentIncidenceInflammationInflammatoryInjuryInterventionInvestigationIraqJournalsK-Series Research Career ProgramsKnock-outLDL-Receptor Related Protein 1LDL-Receptor Related ProteinsLeadLearningLinkLipidsLipoproteinsManuscriptsMeasurementMeasuresMediatingMemory LossMentorsMilitary PersonnelModelingMusNecrosisNeurodegenerative DisordersNeurologicNeurologic DeficitNeurological ModelsNeuronsNeurosciencesOutcomePathologicPathologyPatientsPlayPost-Traumatic Stress DisordersProteinsPublishingRecording of previous eventsRecoveryRecyclingResearchResearch PersonnelRiskRoleSignal TransductionStressStructureSurfaceSystemTNF geneTNFRSF1A geneTestingTimeTrainingTraumatic Brain InjuryVeteransWarWorkapolipoprotein E-3apolipoprotein E-4blood-brain barrier permeabilizationcareercell typecytokinedesigneffective therapyimprovedinnovationmilitary veteranmouse modelnegative affectnervous system disorderneuropathologynoveloutcome predictionpreventprotein expressionreceptorreceptor mediated endocytosisreceptor recyclingresponseresponse to injuryshear stresssymposiumtraining opportunitytumor
中文摘要
本职业发展奖励提案旨在定义预测未来结果的潜在机制
英文摘要
This career development award proposal aims to define potential mechanisms that predict outcome after
traumatic brain injury (TBI), while at the same time providing the applicant with training opportunities within the
VA. TBI affects approximately 15% military population. Veterans were subjected to repeated TBI are at increased
risk of developing long-term neurodegenerative disorders. Treatment options are limited, mainly because the
pathology behind neurological deficits due to TBI is poorly understood.
Apolipoprotein E (ApoE) has several alleles, and patients that express the E4 allele have worse outcomes,
particularly in the long term after TBI. Despite a wide range of studies centered on the ApoE4 allele, none can
be found that investigate the influence of a major ApoE receptor, low density lipoprotein related protein 1 (LRP1),
on outcomes after TBI. Nevertheless, evidence suggests that LRP1 can play a role in modulating TBI outcome-
-LRP1 removes a large variety of cellular proteins, both from the plasma membrane and in the cytosol, and plays
an important role in determining protein expression at the plasma membrane.
ApoE4 enters cells by binding to LRP1 and undergoing receptor mediated endocytosis. In contrast to other
ApoE alleles (E2, E3), ApoE4 endocytosis and receptor recycling are impaired. In the case of LRP1, impaired
recycling is postulated to greatly alter ability of LRP1 to act as a clearance receptor, therefore changing the milieu
of proteins expressed on the plasma membrane and so altering cellular response to damage. For this proposal,
I am focused on understanding the contribution of LRP1 to TBI pathology in a single cell type, astrocytes. Not
only are astrocytes the primary producers of ApoE in the brain, they also play a tremendous role in determining
outcome by limiting secondary spread of damage after TBI. My working hypothesis is that critical LRP1
function is disrupted by ApoE4 binding in astrocytes, thereby modulating normal cellular responses and
sensitizing the brain to inflammation and cell death after TBI. My research strategy will test this hypothesis
while also providing clear training objectives and career opportunities in order to develop independence.
Aim 1 tests the hypothesis that loss of astrocyte LRP1 worsens outcome in TBI. Astrocyte-specific LRP1
mice have been generated, and mouse TBI models will test outcome in the acute and chronic outcome. Aim 2
will test the hypothesis that the impact of ApoE4 on TBI outcome depends on LRP1. TBI-like cell culture models
will mechanistically test the influence of ApoE4 and LRP1 on cell survival. One new mouse line will be generated
by crossing ApoE4 targeted replacement mice into the astrocyte-LRP1 knockout model, and then the effect on
outcome after TBI will be tested similar to aim 1. Aim 3 tests the hypothesis that ApoE4 worsens outcome by
increasing signaling through the inflammatory tumor necrosis alpha receptor 1 (TNFR1), elevating cytokine
stimulated cell death. This aim will be tested mechanistically using cell culture models to test the influence of
ApoE4 and LRP1 on TNFR1 plasma membrane expression, recycling, and TNFR1-mediated cell death.
My career goal is to become a successful independent investigator within the VA system, eventually obtaining
MERIT funding and contributing to better outcomes in Veterans with TBI. I have assembled a team that includes
experts in the field of LRP1 biology, neuroscience, and most importantly, TBI. The scientific objectives will
prepare me for a career studying the effects of TBI in mouse models, while the career objectives will improve
scientific critical thinking and provide opportunities for networking and presentation of my results. These will be
achieved via biannual evaluation by the advisory committee, attendance at national conferences, attending
journal club, improving grantsmanship, and publishing manuscripts resulting from the proposed work. My co-
mentors will also provide training related to proper direction of a successful independent research lab. Altogether,
I expect that the activities detailed in this proposal will provide an exceptional environment from which to start
an independent career.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3171/2018.12.focus18206
发表时间:
2019-03
期刊:
Neurosurgical focus
影响因子:
4.1
作者:
[D. Wallace;Naomi L. Sayre;T. T. Patterson-T.;Susannah E. Nicholson;D. Hilton;Ramesh Grandhi;Ramesh Grandhi]
通讯作者:
D. Wallace;Naomi L. Sayre;T. T. Patterson-T.;Susannah E. Nicholson;D. Hilton;Ramesh Grandhi;Ramesh Grandhi
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
-
批准号:10701231
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2023
-
负责人:Naomi Ledene Sayre
-
依托单位:
海外基金